These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7100807)

  • 1. [Study of antihistone and anti-bicatenary RNA antibodies in connective tissue diseases using immunoenzyme technic].
    Gioud M; Ait Kaci A; Sepetjan M; Monier JC
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):385-91. PubMed ID: 7100807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical application of an ELISA technique for the detection of antihistone antibodies.
    Epstein A; Greenberg M; Halbert S; Kramer L; Barland P
    J Rheumatol; 1986 Apr; 13(2):304-7. PubMed ID: 3522897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis.
    Costa O; Monier JC
    J Rheumatol; 1986 Aug; 13(4):722-5. PubMed ID: 3772919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical importance of antibodies against double-stranded ribonucleic acid in systemic lupus erythematosus and similar diseases of connective tissue.
    Cebecauer L; Rovenský J; Poverenny AM; Podgorodnichenko VK; Doskocil J; Zitnan D
    Czech Med; 1979; 2(3):134-40. PubMed ID: 535500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis.
    Costa O; Pinatel K; Monier JC
    J Rheumatol; 1985 Oct; 12(5):928-33. PubMed ID: 2418204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgG-type antihistone antibodies. Diagnostic value in rheumatoid polyarthritis, scleroderma, spontaneous and drug-induced lupus].
    Meyer O; Cyna L; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Jun; 51(6):303-10. PubMed ID: 6382565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I; Dostal C; Becvar R
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.
    Rosenbaum J; Pottinger BE; Woo P; Black CM; Loizou S; Byron MA; Pearson JD
    Clin Exp Immunol; 1988 Jun; 72(3):450-6. PubMed ID: 3168322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
    Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
    Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of antinuclear anti-histone antibodies].
    Ferec C; Youinou P; Le Goff P; Miossec P; Morin JF; Pennec Y; Morin PP; Le Menn G
    Ann Med Interne (Paris); 1984; 135(6):427-30. PubMed ID: 6334466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine systemic lupus erythematosus. II: Antinuclear antibodies.
    Monier JC; Ritter J; Caux C; Chabanne L; Fournel C; Venet C; Rigal D
    Lupus; 1992 Oct; 1(5):287-93. PubMed ID: 1284631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.
    Mouritsen S; Demant E; Permin H; Wiik A
    Clin Exp Immunol; 1986 Oct; 66(1):68-76. PubMed ID: 3802575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological markers in inflammatory rheumatic diseases.
    Hilliquin P
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihistone antibodies detected by micro-ELISA and immunoblotting in mice with lupus-like syndrome (MRL/1, MRL/n, PN, and NZB strains).
    Costa O; Monier JC
    Clin Immunol Immunopathol; 1986 Aug; 40(2):276-82. PubMed ID: 3720026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
    Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
    Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinucleosome antibody is a major autoantibody in localized scleroderma.
    Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
    Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.